Ars Technica on Nostr: $158,000 ALS drug pulled from market after failing in large clinical trial The drug ...
$158,000 ALS drug pulled from market after failing in large clinical trial
The drug is now unavailable to new patients; its maker to lay off 70% of employees.
https://arstechnica.com/science/2024/04/158000-als-drug-pulled-from-market-after-failing-in-large-clinical-trial/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
The drug is now unavailable to new patients; its maker to lay off 70% of employees.
https://arstechnica.com/science/2024/04/158000-als-drug-pulled-from-market-after-failing-in-large-clinical-trial/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social